{"filing":{"accession_number":"0001213900-26-112075","cik":"0001723059","ticker":"BIOE","company_name":"Bio Essence Corp","form":"8-K","filing_date":"2026-10-23","report_date":"2026-10-15","primary_document":"ea0309555-8k_bioessence.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1723059/000121390026112075/ea0309555-8k_bioessence.htm"},"events":[{"id":37558,"run_id":34612,"accession_number":"0001213900-26-112075","anchor_item_number":"5.02","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"Bio Essence Corp's Board of Directors was expanded from three to ten members through a shareholder-approved bylaw amendment effective October 19, 2026, and two new directors, Thea Zhang and Geoff Fellows, were elected and appointed to the Board.","company_name":"Bio Essence Corp","ticker":"BIOE","filing_date":"2026-10-23","form":"8-K","submitted_at":null,"items":[{"id":42312,"accession_number":"0001213900-26-112075","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the election and appointment of two directors, Thea Zhang and Geoff Fellows, to Bio Essence Corp's Board of Directors effective October 19, 2026, by shareholder written consent. The Item 5.02 disclosure centers on the principal action of these individuals taking board roles, supported by their acceptance letters (Exhibits 99.2 and 99.3) and the shareholder consent resolution (Exhibit 99.1). This is a material governance event affecting board composition.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-23T19:44:41.069086+00:00","company_name":"","ticker":null,"filing_date":""},{"id":42313,"accession_number":"0001213900-26-112075","item_number":"5.03","item_title":"Amendments to Articles of Incorporation","event_type":"governance_other","event_domain":"governance","is_material":false,"confidence":0.85,"reasoning":"This disclosure concerns a shareholder-approved amendment to the Company's Bylaws to increase the authorized number of Directors from three to ten, along with the election of two new directors (Xiying Zhang and Geoff Fellows). While the bylaw amendment itself is a governance matter, it is routine administrative in nature—expanding board capacity does not materially affect investor assessment of the registrant's financial condition, operations, or risk profile. The director appointments are incidental to the bylaw change and do not constitute a material executive appointment in the sense of a C-suite officer or transformative leadership change.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-23T19:44:41.069086+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":42312,"accession_number":"0001213900-26-112075","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the election and appointment of two directors, Thea Zhang and Geoff Fellows, to Bio Essence Corp's Board of Directors effective October 19, 2026, by shareholder written consent. The Item 5.02 disclosure centers on the principal action of these individuals taking board roles, supported by their acceptance letters (Exhibits 99.2 and 99.3) and the shareholder consent resolution (Exhibit 99.1). This is a material governance event affecting board composition.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-23T19:44:41.069086+00:00","company_name":"Bio Essence Corp","ticker":"BIOE","filing_date":"2026-10-23"},{"id":42313,"accession_number":"0001213900-26-112075","item_number":"5.03","item_title":"Amendments to Articles of Incorporation","event_type":"governance_other","event_domain":"governance","is_material":false,"confidence":0.85,"reasoning":"This disclosure concerns a shareholder-approved amendment to the Company's Bylaws to increase the authorized number of Directors from three to ten, along with the election of two new directors (Xiying Zhang and Geoff Fellows). While the bylaw amendment itself is a governance matter, it is routine administrative in nature—expanding board capacity does not materially affect investor assessment of the registrant's financial condition, operations, or risk profile. The director appointments are incidental to the bylaw change and do not constitute a material executive appointment in the sense of a C-suite officer or transformative leadership change.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-23T19:44:41.069086+00:00","company_name":"Bio Essence Corp","ticker":"BIOE","filing_date":"2026-10-23"}]}